. Author manuscript; available in PMC: 2018 Jan 15.

Published in final edited form as: Int J Cardiol. 2016 Nov 4;227:462–466. doi: 10.1016/j.ijcard.2016.11.006

Table 2.

Associations of discharge prescription for spironolactone with outcomes at 30 days post-discharge in a propensity score matched cohort of hospitalized patients for heart failure and reduced ejection fraction

	(Events %) Spironolactone on discharge		HR (95% CI); p-value
	No (n=324)	Yes (n=324)	HR (95% CI); p-value
All-cause readmission	18.8%	17.3%	0.92 (0.64–1.30); 0.650
Heart failure readmission	8.3%	6.2%	0.74 (0.41–1.31); 0.737
All-cause mortality	4.0%	3.4%	0.84 (0.38–1.88); 0.844
All-cause mortality or readmission	21.9%	19.8%	0.90 (0.64–1.27); 0.902

HR = hazard ratio; CI = confidence interval